Trial Profile
A retrospective study evaluating the true rate of urinary retention requiring clean intermittent catheterization in overactive bladder patients treated with onabotulinumtoxin A injection in real world
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- 06 Dec 2018 New trial record